Home » ETF » GERM

GERM - ETFMG Treatments Testing and Advancements ETF

Stock Price: $36.65 USD -0.47 (-1.27%)
Updated Apr 19, 2021 4:00 PM EDT - Market closed
Assets $54.23M
NAV $34.99
Expense Ratio 0.68%
PE Ratio n/a
Beta (5Y) 2.36
Dividend (ttm) $0.28
Dividend Yield 0.81%
Ex-Dividend Date Dec 14, 2020
1-Year Return -
Trading Day April 19
Last Price $36.65
Previous Close $37.12
Change ($) -0.47
Change (%) -1.27%
Day's Open 36.73
Day's Range 36.44 - 37.30
Day's Volume 16,331
52-Week Range 23.60 - 44.69

Fund Description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Treatments, Testing and Advancements Index. The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.

Asset Class
Equity
Inception Date
Jun 17, 2020
Exchange
NYSEARCA
Ticker Symbol
GERM
Index Tracked
Prime Treatments, Testing and Advancements Index

Top 10 Holdings

51.09% of assets
NameSymbolWeight
BioNTech SEBNTX6.87%
LabCorpLH6.18%
Bio-Rad LaboratoriesBIO5.91%
Alnylam PharmaceuticalsALNY5.91%
ModernaMRNA5.73%
CureVacCVAC4.22%
Quest DiagnosticsDGX4.18%
NovavaxNVAX4.17%
AbCellera BiologicsABCL4.02%
Zai LabZLAB3.90%
View All Holdings

Dividends

Ex-DividendAmountPay Date
Dec 14, 2020$0.285Dec 16, 2020
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

Last week was upbeat for Wall Street with the S&P 500 and the Dow Jones closing out at a record high.

Other tickers mentioned: BDRY, COPX, SGG, UNG
15 hours ago - Zacks Investment Research

Covid-19 has put healthcare stocks in the limelight. These seven companies should be on your radar for the next pandemic.

Other tickers mentioned: DHR, GILD, HOLX, IMVT, PFE, XLV
2 weeks ago - InvestorPlace

The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak considering the pandemic's renewed resurgence thanks to variants. Thus, a COVID-themed ETF could be a smart p...

Other tickers mentioned: EDOC, EDUT, VIRS, WFH
3 weeks ago - Zacks Investment Research

The first month of 2021 was pretty volatile. While stocks were at their all-time highs in first part of January, some downbeat economic data points as well as the retail trading frenzy in some specific ...

Other tickers mentioned: DJP, GAZ, IWM, SILJ, SLVP, VPN
2 months ago - Zacks Investment Research

The three indices logged in their worst week since October, dropping more than 3% each, sending the Dow Jones and S&P 500 into the red for the first month of 2021.

Other tickers mentioned: GAMR, POTX, PRNT, XRT
2 months ago - Zacks Investment Research

Simple profit-booking and some warnings from the too-big-to-fail companies probably led to crash in Wall Street last week.

Other tickers mentioned: ACWI, CORN, DIA, GAMR, IWM, PSCD, QQQ ...
2 months ago - Zacks Investment Research

The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.

Other tickers mentioned: EDOC, EDUT, VIRS, WFH
3 months ago - Zacks Investment Research

The S&P 500, the Dow Jones and the Nasdaq Composite -- all three indexes touched all-time closing highs to end last week.

Other tickers mentioned: AMZA, ARKG, COPX, IEZ, MSOS, POTX
4 months ago - Zacks Investment Research

The rest of 2020 and the beginning of 2021 are expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.

Other tickers mentioned: EDOC, EDUT, VIRS, WFH
4 months ago - Zacks Investment Research

There was big news on the coronavirus vaccine front Monday when Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) said their vaccine delivered an impressive showing in Phase 3 trials. What Happened: Alone,...

5 months ago - Benzinga

The remainder of 2020 is expected to continue bearing the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.

Other tickers mentioned: EDOC, EDUT, VIRS, WFH
5 months ago - Zacks Investment Research

As the race to develop a vaccine continues, these biotech stocks could be high risk, high return propositions. The post 7 Biotech Stocks To Buy For Profit From The Vaccine Crunch appeared first on Inves...

Other tickers mentioned: GILD, FBT, PFE, REGN, WST
6 months ago - InvestorPlace

It feels like the rest of 2020 will continue to bear the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.

Other tickers mentioned: EDOC, EDUT, VIRS, WFH
6 months ago - Zacks Investment Research

Amid the uncertainties, a few sectors have survived last week's turmoil. We have highlighted six of that could be compelling picks for the weeks ahead as long as volatility persists.

Other tickers mentioned: AZN, CNCR, ITB, MXI, RING, TAN
7 months ago - Zacks Investment Research

There are advantages -- and disadvantages -- to some of the newest ETFs on the market.

Other tickers mentioned: VIRS, WFH
7 months ago - The Motley Fool

In the current scenario of the rising work-from-home and online shopping trends, online learning, home entertainment, telemedicine and digital health services are slowly becoming the "new normal."

Other tickers mentioned: EDOC, EDUT, VIRS
7 months ago - Zacks Investment Research

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

Other tickers mentioned: BBH, BTEC, CNCR, IBB, IDNA, XBI
7 months ago - Zacks Investment Research

In the current scenario of the rising work-from-home and online shopping trends, online learning, home entertainment, telemedicine and digital health services are slowly becoming the "new normal."

Other tickers mentioned: EDOC, EDUT, VIRS
7 months ago - Zacks Investment Research

Investing in coronavirus themed ETFs which focus on companies involved in testing and treatment

YouTube video

ETF Managers Group CEO Sam Masucci discusses GERM an ETF that invests in companies that are focused on COVID-19 treatment and testing.

8 months ago - Yahoo Finance

Should You Invest in COVID Themed ETFs?

YouTube video

We highlight three new ETFs that seek to capitalize on coronavirus.

Other tickers mentioned: VIRS, WFH
8 months ago - Zacks Investment Research

Biotech ETFs are, in a word, hot.

Other tickers mentioned: BTEC, CNCR, IBB, PBE, XBI
8 months ago - Kiplinger

Biotech ETFs are popular and delivering for investors, but not all of these funds need the Covid-19 pandemic to soar.

Other tickers mentioned: ARKG, BTEC, CNCR, FBT, SBIO, XBI
8 months ago - InvestorPlace

There are at least a hundred candidates in the COVID-19 vaccine race globally. However, few companies like Moderna, Pfizer and AstraZeneca are showing considerable hope.

Other tickers mentioned: AZN, FTXH, MRNA, NVAX, PFE, PPH, PTH ...
8 months ago - Zacks Investment Research

We have highlighted ETFs from the best and worst zones to start the third quarter.

Other tickers mentioned: KBWR, TAN, VXX
8 months ago - Zacks Investment Research

An unusually high number of launches in June boosted the open-to-close ratio. 

Other tickers mentioned: BETZ, WFH
9 months ago - ETFcom

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

Other tickers mentioned: MRNA, BBH, BTEC, CNCR, FBT, IBB, IDNA ...
9 months ago - Zacks Investment Research

The reason I mentioned iBio’s addition to the indexes is that it shows how little investors really know about what’s happening behind the scenes at iBio’s vaccine central. There's a dearth of informatio...

9 months ago - InvestorPlace

Overall, the S&P 500 is down 1.6% this year (as of Jul 6, 2020) while the Nasdaq Composite has gained 16.3% in the year-to-date frame. The Dow Jones has suffered the most with 7.9% year-to-date loss.

Other tickers mentioned: CRAK, GDXJ, GOEX, IBUY, JKE, MGK, SILJ ...
9 months ago - Zacks Investment Research

At the start of Q3, the operating and investing backdrop looks mixed. The second wave of virus contagion has already hit the market and threatening the speed of recovery while several economic data poin...

Other tickers mentioned: OGIG, SPYG, WCLD, XLG, XLP, XLV, XLY
9 months ago - Zacks Investment Research

At the onset of 2H, the operating and investing backdrop looks mixed as the second wave of virus contagion has already hit while several economic datapoints are coming in upbeat thanks to the unlocking ...

Other tickers mentioned: PKB, XLU, XLV, XRT
9 months ago - Zacks Investment Research

The first half of 2020 was all about the outbreak of coronavirus in late January, which is going to stay in the second half too. So, some issuers have launched specific COVID-19-focused ETFs in recent w...

9 months ago - Zacks Investment Research

Last week was downbeat for Wall Street with the S&P 500 losing about 2.9%.

Other tickers mentioned: CHIK, DWSH, FAAR, PDEV, SGDJ
9 months ago - Zacks Investment Research

The race for a Covid-19 vaccine will bring eyes to the new GERM ETF, but there's long-term available here, too. The post New GERM ETF Debuts at Just the Right Time appeared first on InvestorPlace.

9 months ago - InvestorPlace

The newest health care exchange-traded fund is unique in that three stalwarts of other industry funds aren’t even among its top holdings.

9 months ago - GuruFocus

GERM invests in the hottest emerging biotechnology trends.

9 months ago - Zacks Investment Research